Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yanyan,Wang

第一单位： Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, PR China.

作者： Yanyan,Wang ^[1] ; Hai,Gao ^[1] ; Xinya,Huang ^[1] ; Zhaoan,Chen ^[1] ; Pengyu,Kang ^[1] ; Yunyi,Zhou ^[1] ; Danhua,Qin ^[1] ; Wenli,Zhang ^[2] ; Jianping,Liu ^[3]

作者单位： Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, PR China. ^[1] Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, PR China. Electronic address: zwllz@163.com. ^[2] Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, PR China. Electronic address: jianpingliu1293@163.com. ^[3]

关键词 Atherosclerosis Cholesterol efflux Efferocytosis Hyaluronan LXR activation Reconstituted high-density lipoprotein Sequential-targeting β-Cyclodextrin

主题词动脉粥样硬化(Atherosclerosis);胆固醇(Cholesterol);环糊精类(Cyclodextrins);人类(Humans);脂蛋白类, HDL(Lipoproteins, HDL);斑块, 动脉粥样硬化(Plaque, Atherosclerotic)

DOI 10.1016/j.carbpol.2022.119632

PMID 35725197

发布时间 2022-06-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交